The selective action of D2 dopamine receptor antisense oligodeoxynucleotide on the expression of the dopamine receptor subtype mRNA in rat striatum

Tokai Journal of Experimental and Clinical Medicine

Volumn 31, Issue 2, 2006, Pages 73-77

  Andoh, Hidehiro ^a   Yoshikawa, Masanobu ^a   Kawaguchi, Mitsuru ^b   Matsumoto, Hideo ^a   Yamazaki, Kosuke ^a   Oka, Tetsuo ^a  

^a TOKAI UNIVERSITY   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

Author keywords

Antisense oligodeoxynucleotide; D2 dopamine receptor; mRNA; Real time PCR

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; MESSENGER RNA; OXIDOPAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; ANIMAL; BIOSYNTHESIS; CORPUS STRIATUM; DRUG EFFECT; GENETICS; METABOLISM; WISTAR RAT;

ANIMALS; CORPUS STRIATUM; GENE EXPRESSION; MALE; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 34249046388     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Baker GB, Greenshaw AJ. Effects of long-term administration of antidepressants and neuroleptics on receptors in the central nervous system. Cell Mol Neurobiol 1989; 9: 1-44.
2. Bunzow JR, Van Tol HH, Grandy DK, Albert P, Salon J, Christie M, et al. Cloning and expression of a rat D2 dopamine receptor cDNA. Nature 1988; 336: 783-7.
3. Carlsson A. The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1988; 1: 179-86.
4. Civelli O, Bunzow JR, Grandy DK, Zhou QY, Van Tol HH. Molecular biology of the dopamine receptors. Eur J Pharmacol 1991; 207: 277-86.
5. Gingrich JA, Caron MG. Recent advances in the molecular biology of dopamine receptors. Annu Rev Neurosci 1993; 16: 299-321.
6. Helene C, Toulme JJ. Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta 1990; 1049: 99-125.
7. Kebabian JW, Calne D. Multiple receptors for dopamine. Nature 1979; 277: 93-6.
8. Mack KJ, Todd RD, O'Malley KL. The mouse dopamine D2A receptor gene: sequence homology with the rat and human genes and expression of alternative transcripts. J Neurochem 1991; 57: 795-801.
9. Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed., San Diego, CA, Academic Press, 1998
10. Seeman P. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 1992; 7: 261-84.
11. Seeman P, Bzowej NH, Guan HC, Bergeron C, Reynolds GP, Bird ED, et al. Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases. Neuropsychopharmacology 1987; 1: 5-15.
12. Seeman P, Guan HC, Van Tol HH and Niznik HB. Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata. Synapse 1993; 14: 247-53.
13. Seeman P, Niznik HB. Dopamine receptors and transporters in Parkinson's disease and schizophrenia. Faseb J 1990; 4: 2737-44.
14. Seeman P, Van Tol HH. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994; 15: 264-70.
15. Sibley DR, Monsma FJ Jr. Molecular biology of dopamine receptors. Trends Pharmacol Sci 1992; 13: 61-9.
16. Spano PF, Govoni S, Trabucchi M. Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. Adv Biochem Psychopharmacol 1978; 19: 155-65.
17. Wahlestedt C. Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol Sci 1994; 15: 42-6.
18. Weiss B, Zhang SP, Zhou LW. Antisense strategies in dopamine receptor pharmacology. Life Sci 1997; 60; 433-55.
19. Weiss B, Zhou LW, Zhang SP, Qin ZH. Antisense oligodeoxynucleotide inhibits D2 dopamine receptor-mediated behavior and D2 messenger RNA. Neuroscience 1993; 55: 607-12.
20. Yoshikawa M, Kobayashi T, Oka T, Kawaguchi M, Hashimoto A. Distribution and MK-801-induced expression of serine racemase mRNA in rat brain by real-time quantitative PCR. Brain Res Mol Brain Res 2004; 128: 90-4.
21. Yoshikawa M, Oka, T, Kawaguchi M, Hashimoto, A. MK-801 upregulates the expression of d-amino acid oxidase mRNA in rat brain. Brain Res Mol Brain Res 2004; 131: 141-4.
22. Yoshikawa M, Yokogami K, Kitamura K, Kobayashi T, Kanai M, Taniguchi T, et al. Time course of changes in mu-opioid receptor mRNA levels in the periaqueductal gray of rat brain by a single or repeated injections of antisense oligodeoxynucleotides. Jpn J Pharmacol 1999; 81: 209-15.
23. Zhang M, Creese I. Antisense oligodeoxynucleotide reduces brain dopamine D2 receptors: behavioral correlates, Neurosci Lett 1993; 161: 223-6.
24. Zhou LW, Zhang SP, Qin ZH, Weiss B. In vivo administration of an oligodeoxynucleotide antisense to the D2 dopamine receptor messenger RNA inhibits D2 dopamine receptor-mediated behavior and the expression of D2 dopamine receptors in mouse striatum. J Pharmacol Exp Ther 1994; 268: 1015-23.
25. Zhou QY, Grandy DK, Thambi L, Kushner JA, Van Tol HH, Cone R, et al. Cloning and expression of human and rat D1 dopamine receptors. Nature 1990; 347: 76-80.